Maybe you’ve bought shares of AI company stocks or invested in ETFs focused on AI, technology, or computer science. Or, ...
By Maggie Fick, Bhanvi Satija and Patricia Weiss LONDON/FRANKFURT, June 10 (Reuters) - Pfizer is reviewing the timing and ...
A symbol of American pharmaceutical innovation for nearly two centuries, Pfizer now faces the challenges of AI adoption and ...
Albert Bourla, Pfizer's chief executiveFabrice Coffrini/AFP/Getty Images Pfizer Chief Executive Albert Bourla is battling impending expirations for some blockbuster-drug patents and the precipitous ...